ArticlesBioPharma March 11, 2024 Bracing for a Future Wave of Advanced Therapies With the help of recent investor interest, progression of advanced therapy medicinal products... admin-element
ArticlesBioPharma March 11, 2024 Are you ready to optimize your oligo synthesis? In this white paper, we share what we learned in our four decades of experience... admin-element
ArticlesBioPharma February 23, 2024 Boosting biopharma resilience: The need to shift focus and increase collaboration Biopharma Resilience is declining. The 2023 Global Biopharma Resilience Index from Cytiva offers insights... admin-element
ArticlesBioPharma January 12, 2024 Exploring the world of antibodies: mAbs, Fabs, dAbs, and bsAbs There is a vast array of antibody variants, including multispecific (msAb), bispecific antibodies... admin-element
ArticlesBioPharma December 1, 2023 Democratizing GMP Manufacturing for the New Therapeutic Pipeline PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with... admin-element
ArticlesBioPharma November 17, 2023 Developing oligonucleotide therapeutics with confidence In this video, we will look at key considerations for oligo therapeutic developers entering the... admin-element
ArticlesBioPharma November 3, 2023 Digitalization: The Route to Biopharma 4.0 Industry 4.0, also known as the Fourth Industrial Revolution (4IR), will result in the digital... admin-element
ArticlesBioPharma October 20, 2023 Ready for a strong start in oligo manufacturing? Are you interested in manufacturing your own oligonucleotide therapeutics but don’t know how to start? admin-element
ArticlesBioPharma October 6, 2023 ML and AI Implementation Insights for Bio/Pharma Manufacturing A recent survey of biopharma industry manufacturing leaders found that creating machine learning... admin-element
ArticlesBioPharma September 8, 2023 Innovations in Downstream Processing Innovations in downstream processing accelerate development, enhance efficiency, and promote sustainability. admin-element